International Journal of Infectious Diseases · 2020 · 19 citations · 8 references
PharmacyDermatologyImmunologyClinical ImmunologyImmunopathologyInflammationAutoimmune DiseasesCorticosteroid TherapyImmune-related Adverse EventsImmunosuppressionImmunosuppressive TherapyInfectious DermatosesDermatologic Adverse EventsLeprosy LesionsLeprosy Reactional StatesLong-term ImmunosuppressionOral Corticosteroid TherapySteroid Combination TherapySteroid DependenceType 2 Immunity
Type 2 leprosy reaction (T2LR), or Erythema Nodosum Leprosum (ENL), often poses a therapeutic challenge to clinicians and commonly requires long courses of steroids for control. While immunosuppressants are known to achieve control and lower steroid dependence in T2LR, the prospect of managing a severe T2LR in conjunction with COVID-19, with the concern of worsening COVID-19 with long-term immunosuppression has not previously been encountered. We report a case of severe T2LR treated with oral steroids and methotrexate, with COVID-19 infection acquired during hospital stay, and a favourable outcome achieved despite the continued use of immunosuppressants. We discuss the possible reasons for this both in terms of the drug pharmacodynamics and the immunological profile of T2LR.
8
Dexamethasone in Hospitalized Patients with Covid-19.
Peter Horby, Wei Shen Lim, Jonathan Emberson et al. · DiRROS repository (University of Maribor) · 2020 · 8K citations · Full text